OCUP Ocuphire Pharma, Inc.

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

$4.18
As of 07/23/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/2005
Outstanding shares:  12,563,989
Average volume:  3,766,820
Market cap:   $55,909,751
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    67577R102
ISIN:        US67577R1023
Sedol:      BKPSQY4
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.35
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy